Search results
Results From The WOW.Com Content Network
Flunitrazepam, sold under the brand name Rohypnol among others, [3] is a benzodiazepine used to treat severe insomnia and assist with anesthesia. [4] As with other hypnotics, flunitrazepam has been advised to be prescribed only for short-term use or by those with chronic insomnia on an occasional basis.
Trouble in Mind: The Doc Watson Country Blues Collection (or simply Trouble in Mind) is the title of a recording by American folk music and country blues artist Doc Watson, released in 2003. It contains recordings by Watson in the country blues style.
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai.Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. [3]
The Generic Product Identifier (GPI) is a 14-character hierarchical classification system created by Wolters Kluwer's Medi-Span that identifies drugs from their primary therapeutic use down to the unique interchangeable product regardless of manufacturer or package size.
In 2014, Cipla acquired control of the company, and the company changed its name to Cipla Quality Chemical Industries Limited (CiplaQCIL). In 2016, the company was converted to a public company. Two years later, in 2018, the company listed on the Uganda Securities Exchange, offering shares to individual and institutional investors in an Initial ...
For premium support please call: 800-290-4726 more ways to reach us
The article noted that major healthcare organizations, such as National Center for Advancing Translational Sciences of the National Institutes of Health, the President's Council of Advisors on Science and Technology, the World Economic Forum, the Gates Foundation, the Wellcome Trust, and the Food and Drug Administration had encouraged greater ...
The blue card is an approved EU-wide work permit (Directive (EU) 2021/1883) [1] allowing highly skilled non-EU citizens to work and live in 25 of the 27 countries within the European Union excluding Denmark and Ireland, which are not subject to the proposal. [2]